x

Search for a clinical trial

* (*) mandatory field

128 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

GERMANY

Hamburg
HAMBURG

Ongoing trial
Phase 3b Study for Management of Ocular Side Effects in Subjects With EGFR-amplified Glioblastoma Receiving Depatuxizumab Mafodotin (ABT-414) -DE-
Hubertus Wald Tumorzentrum/ Universitäres Cancer Center (UCCH)
Comprehensive Cancer Center (CCC) Hamburg

UNITED KINGDOM

Greater London
LONDON

AUSTRIA

WIEN
WIEN

Ongoing trial
Pharmacokinetics of temozolomide in cerebrospinal fluid in children with malignant brain tumors (phase 1)
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Neonatologie, Pädiatrische Intensivmedizin und Neuropädiatrie

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

FRANCE

AUVERGNE-RHONE-ALPES
BRON

Recruiting trial
Ongoing trial
Randomized, Prospective, Multicenter Blinding Singles With Arm A and Arm B Innovative Strategy Strategy Conventional (Phase III) - FR
CHU de Lyon HCL - GH Est-Hôpital Neurologique P. Wertheimer
Service de neurochirurgie tumorale - chirurgie des malformations vasculaires du systéme nerveux

FRANCE

ILE-DE-FRANCE
BOBIGNY

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
A Prospective, Multi-center Phase III Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed Glioblastoma Multiforme
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
Service de Neurologie 2 : Unité d'Onco-Neurologie

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
ONCOVIRAC : Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients (Phase I-II)
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
Service de Neurologie 2 : Unité d'Onco-Neurologie

FRANCE

OCCITANIE
TOULOUSE

FRANCE

PROVENCE-ALPES-COTE D'AZUR
NICE

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

Ongoing trial
GERAS: Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation in Elderly Patients With Glioblastoma
Neurologische Universitätsklinik Heidelberg
Klinik für Radioonkologie und Strahlentherapie

GERMANY

Baden-Württemberg
TÜBINGEN

GERMANY

Bayern
MÜNCHEN

Recruiting trial
Ongoing trial
GlioCave/NOA17: Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma (Phase 2) - DE
Klinikum rechts der Isar der Technischen Universität München
Klinik und Poliklinik für RadioOnkologie und Strahlentherapie

GERMANY

Berlin
BERLIN

Recruiting trial
Ongoing trial
The C-GBM Study: Prospective controlled phase II trial of Cabazitaxel in patients with Temozolomide refractory Glioblastoma Multiforme - DE
Charité - Universitätsmedizin Berlin (CVK)
Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie

GERMANY

Niedersachsen
GÖTTINGEN

GERMANY

Nordrhein-Westfalen
ESSEN

Recruiting trial
Ongoing trial
PriCoTTF - PriCoTTF Study: A phase I/II study with TTFields before and during radiotherapy in newly diagnosed glioblastoma
Westdeutsches Tumorzentrum Essen (WTZ)
Klinik für Innere Medizin (Tumorforschung)

ITALY

EMILIA ROMAGNA
MELDOLA

Ongoing trial
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma: a Phase II Study
IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori
Dipartimento di Oncologia ed ematologia clinica e sperimentale

ITALY

LAZIO
ROMA

Recruiting trial
Ongoing trial
Repurposing the Antipsychotic Drug Chlorpromazine as a Therapeutic Agent in the Combined Treatment of Newly Diagnosed Glioblastoma Multiforme
Istituti Fisioterapici Ospitalieri - Istituto Nazionale Tumori Regina Elena
Dipartimento per lo Sviluppo dei Programmi Terapeutici

NETHERLANDS

Limburg
MAASTRICHT

NETHERLANDS

Zuid-Holland
ROTTERDAM

SWITZERLAND

Suisse Alémanique
BERN

Ongoing trial
RESDEX - Restrictive Use of Dexamethasone in Glioblastoma
Universitätsspital Inselspital
Universitätsklinik für Neurochirurgie

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Bayern
REGENSBURG

Recruiting trial
Ongoing trial
INFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Universitätsklinikum Regensburg
Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation

GERMANY

Nordrhein-Westfalen
ESSEN

Recruiting trial
Ongoing trial
INFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Universitätsklinikum Essen
Klinik für Kinderheilkunde III - Abteilung für pädiatrische Hämatologie und Onkologie

ITALY

LOMBARDIA
MILANO

Recruiting trial
Ongoing trial
Phase II, open label, monocentric, uncontrolled, non randomized clinical trial on Sodium Fluorescein for Surgery of High Grade Gliomas
Fondazione IRCCS Istituto Neurologico "Carlo Besta"
UOC Neurochirurgia 2 - Neurochirurgia Vascolare

FRANCE

AUVERGNE-RHONE-ALPES
GRENOBLE

AUSTRIA

NIEDERÖSTERREICH
ST. PÖLTEN

Ongoing trial
LAHENE Study: Perioperative Levetiracetam for seizure prophylaxis in brain tumor patients. Prospective evaluation of side effects and efficacy (phase 2)
Universitätsklinikum St. Pölten
Karl Landsteiner Institut für klinische Neurologie und Neuropsychologie

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Recruiting trial
Ongoing trial
BIOMEDE: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication (Phase II) - FR
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ongoing trial
STEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique

Multinational clinical trial(s)

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

GERMANY

Baden-Württemberg
TÜBINGEN